Circulation 2015 Jul;132(1):e6-9
From Hemophilia and Thrombosis Center and Clot Connect Program (www.clotconnect.org), University of North Carolina School of Medicine, Chapel Hill (S.M.); Division of Hematology/Oncology/Bone Marrow Transplant, Nationwide Children's Hospital, Columbus, OH (E.A.V.); and The Ohio State University College of Medicine, Columbus (E.A.V.).
J Stroke Cerebrovasc Dis 2021 Apr 1;30(6):105744. Epub 2021 Apr 1.
Division of Neurology, Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli", Naples, Italy. Electronic address:
Background And Objectives: Pseudoxanthoma elasticum (PXE) is a rare autosomal recessive disorder caused by pathogenic variants in the ABCC6 gene. The phenotypic spectrum of PXE is highly variable and includes principally three major features: skin lesions, eye and vascular manifestations, while brain manifestations are less common. To date about 400 different PXE associated variants in ABCC6 gene are described without any evident genotype-phenotype correlation. Read More
Chin Med J (Engl) 2021 Mar 25. Epub 2021 Mar 25.
Department of Pediatrics, Peking University First Hospital, Beijing 100034, China.
Angiology 2021 Mar 30:33197211005614. Epub 2021 Mar 30.
Diabetes Centre, Tameside Hospital NHS Foundation Trust and University of Manchester, Lancashire, United Kingdom.
Autologous cell therapy (ACT) is a new treatment for patients with no-option critical limb ischemia (NO-CLI). We evaluated the factors involved in the nonresponse to ACT in patients with CLI and diabetic foot. Diabetic patients (n = 72) with NO-CLI treated using ACT in our foot clinic over a period of 8 years were divided into responders (n = 57) and nonresponders (n = 15). Read More
Clin Chem Lab Med 2021 Mar 25. Epub 2021 Mar 25.
Division of Clinical Pathology, Department of Surgical, Medical, Dental and Morphological Sciences with Interest in Transplant, Oncological and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.
Eur J Ophthalmol 2021 Mar 9:11206721211000647. Epub 2021 Mar 9.
Hospital de Santa Maria, Lisboa, Portugal.
The role of polymorphisms of methylenetetrahydrofolate reductase (MTHFR) gene in retinal vein occlusion (RVO) is a theme of discussion since the first reports of RVO in patients with MTHFR C677T mutation and without classic acquired risk factors for retinal vascular disease. The association between MTHFR polymorphisms and RVO has been studied over the last 20 years producing conflicting results. This review aims to summarize the literature concerning the role MTHFR polymorphisms as risk factors for RVO. Read More